Characterisation of Gene Variants in the Angiogenic Pathway
Condition(s):Solid TumorsLast Updated:January 14, 2014Unknown status
Hide Studies Not Open or Pending
Condition(s):Solid TumorsLast Updated:January 14, 2014Unknown status
Condition(s):Breast CancerLast Updated:March 7, 2024Completed
Condition(s):Renal Cell CarcinomaLast Updated:February 26, 2020Completed
Condition(s):C-staged Hepatocellular Carcinoma in BCLC ClassificationLast Updated:June 16, 2022Recruiting
Condition(s):C-staged Hepatocellular Carcinoma in BCLC ClassificationLast Updated:September 13, 2023Recruiting
Condition(s):Advanced or Metastatic Solid MalignancyLast Updated:April 7, 2017Terminated
Condition(s):CancerLast Updated:June 25, 2021Completed
Condition(s):Hepatocellular Carcinoma RecurrentLast Updated:March 14, 2022Unknown status
Condition(s):Objective Response Rate; Progression-free Survival; Overall Survival; Disease Control Rate; Duration of Response; Five-year Survival Rate; Quality of LifeLast Updated:March 29, 2023Recruiting
Condition(s):Colorectal CancerLast Updated:February 13, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.